ArticleRSC medicinal chemistry2023

Novel 1,2,4-oxadiazole compounds as PPAR-α ligand agonists: a new strategy for the design of antitumour compounds.

Luis Apaza Ticona et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.